Regn investor alert: bronstein, gewirtz and grossman, llc announces that regeneron pharmaceuticals, inc. investors with losses have opportunity to lead class action lawsuit!

New york city, ny / access newswire / february 2, 2025 / bronstein, gewirtz & grossman, llc, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against regeneron pharmaceuticals, inc. ("regeneron" or "the company") (nasdaq:regn) and certain of its officers. class definition this lawsuit seeks to recover damages against defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired regeneron securities between november 2, 2023 and october 30, 2024, both dates inclusive (the "class period").
REGN Ratings Summary
REGN Quant Ranking